Pictet North America Advisors Sa Astrazeneca PLC Transaction History

Pictet North America Advisors Sa

$1.05 Trillion
Q4 2024

A detailed history of Pictet North America Advisors Sa transactions in Astrazeneca PLC stock. As of the latest transaction made, Pictet North America Advisors Sa holds 95,562 shares of AZN stock, worth $6.78 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

95,562

Previous 30,425 214.09%

Holding current value

$6.78 Million

Previous $2.37 Billion 164.14%

% of portfolio

0.6%

Previous 0.23%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$63.2 - $79.58 $4.12 Million - $5.18 Million	65,137 Added 214.09%	95,562 $6.26 Billion
Q2 2024 Jul 25, 2024	SELL	$66.81 - $80.83 $2.16 Million - $2.61 Million	-32,308 Reduced 51.5%	30,425 $2.37 Billion
Q1 2024 May 03, 2024	SELL	$61.03 - $69.57 $605,173 - $689,856	-9,916 Reduced 13.65%	62,733 $4.25 Billion
Q4 2023 Feb 09, 2024	SELL	$61.89 - $69.28 $412,806 - $462,097	-6,670 Reduced 8.41%	72,649 $4.89 Billion
Q3 2023 Nov 03, 2023	SELL	$64.85 - $71.7 $4.2 Million - $4.64 Million	-64,699 Reduced 44.92%	79,319 $5.37 Billion
Q2 2023 Aug 04, 2023	SELL	$69.91 - $75.81 $458,329 - $497,010	-6,556 Reduced 4.35%	144,018 $10.3 Billion
Q1 2023 May 04, 2023	SELL	$63.15 - $71.6 $1.92 Million - $2.18 Million	-30,385 Reduced 16.79%	150,574 $10.5 Billion
Q4 2022 Mar 22, 2023	SELL	$54.21 - $70.44 $340,980 - $443,067	-6,290 Reduced 3.36%	180,959 $12.3 Billion
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $97,609 - $249,915	-1,841 Reduced 0.97%	187,249 $10.3 Billion
Q2 2022 Aug 05, 2022	SELL	$59.26 - $71.14 $506,910 - $608,531	-8,554 Reduced 4.33%	189,090 $12.5 Million
Q1 2022 May 06, 2022	BUY	$55.72 - $67.12 $81,072 - $97,659	1,455 Added 0.74%	197,644 $13.1 Million
Q4 2021 Feb 04, 2022	SELL	$54.02 - $63.83 $121,653 - $143,745	-2,252 Reduced 1.13%	196,189 $11.4 Million
Q3 2021 Nov 10, 2021	SELL	$55.56 - $60.79 $2.04 Million - $2.23 Million	-36,748 Reduced 15.62%	198,441 $24 Million
Q2 2021 Aug 11, 2021	BUY	$48.42 - $60.18 $132,767 - $165,013	2,742 Added 1.18%	235,189 $28.2 Million
Q1 2021 May 10, 2021	BUY	$47.16 - $54.44 $231,508 - $267,245	4,909 Added 2.16%	232,447 $23.2 Million
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $127,510 - $152,476	2,628 Added 1.17%	227,538 $22.8 Million
Q3 2020 Nov 10, 2020	SELL	$53.07 - $61.1 $215,358 - $247,943	-4,058 Reduced 1.77%	224,910 $24.6 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $117,361 - $150,609	-2,723 Reduced 1.18%	228,968 $23.8 Million
Q1 2020 Apr 30, 2020	SELL	$37.79 - $51.33 $71,007 - $96,449	-1,879 Reduced 0.8%	231,691 $20.7 Million
Q4 2019 Jan 31, 2020	BUY	$42.46 - $50.46 $57,660 - $68,524	1,358 Added 0.58%	233,570 $23.5 Million
Q3 2019 Nov 08, 2019	BUY	$40.12 - $45.47 $670,204 - $759,576	16,705 Added 7.75%	232,212 $20.8 Million
Q2 2019 Aug 07, 2019	SELL	$37.28 - $41.68 $949,409 - $1.06 Million	-25,467 Reduced 10.57%	215,507 $17.7 Million
Q1 2019 May 01, 2019	SELL	$35.49 - $43.02 $1.24 Million - $1.51 Million	-34,994 Reduced 12.68%	240,974 $19.3 Million
Q4 2018 Jan 31, 2019	SELL	$36.86 - $41.49 $150,462 - $169,362	-4,082 Reduced 1.46%	275,968 $20.6 Million
Q3 2018 Nov 07, 2018	BUY	$34.76 - $39.72 $145,296 - $166,029	4,180 Added 1.52%	280,050 $21.8 Million
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $88,586 - $94,996	-2,564 Reduced 0.92%	275,870 $19.1 Million
Q1 2018 May 08, 2018	BUY	$32.97 - $36.63 $451,853 - $502,014	13,705 Added 5.18%	278,434 $19.1 Million
Q4 2017 Feb 09, 2018	SELL	$32.09 - $34.78 $61,612 - $66,777	-1,920 Reduced 0.72%	264,729 $18.3 Million
Q3 2017 Nov 07, 2017	SELL	$28.96 - $34.0 $20,474 - $24,038	-707 Reduced 0.26%	266,649 $17.7 Million
Q2 2017 Aug 09, 2017	BUY	N/A	267,356	267,356 $17.8 Million

Others Institutions Holding AZN

# of Institutions

1,336

Shares Held

477M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet North America Advisors Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet North America Advisors Sa with notifications on news.

Account

Pictet North America Advisors Sa Astrazeneca PLC Transaction History